Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 May;79(1):109–119. doi: 10.1111/j.1476-5381.1983.tb10502.x

The determination of presynaptic pA2 values of yohimbine and phentolamine on the perfused rat heart under conditions of negligible autoinhibition.

H Fuder, E Muscholl, R Spemann
PMCID: PMC2044845  PMID: 6307450

Abstract

1 Rat isolated perfused hearts with the right sympathetic nerves attached were loaded with [3H]-(-)-noradrenaline. The nerves were stimulated with up to 40 trains of 10 pulses every min at 1 Hz, and the evoked increases of [3H-]noradrenaline overflow into the perfusate, of right atrial tension development and ventricular beating frequency were measured. 2 Oxymetazoline inhibited the evoked transmitter overflow (IC50: 10 nM) and decreased the postsynaptic responses in a concentration-dependent manner. It behaved as a full against in abolishing the evoked transmitter overflow. 3 Yohimbine up to 1 microM neither enhanced the evoked [3H]-noradrenaline overflow nor the postsynaptic parameters. Phentolamine (1 microM) caused a transient, minor (less than 30%) increase in [3H]-noradrenaline overflow. 4 Yohimbine (0.03-1.0 microM) and phentolamine (0.1-5.0 microM) shifted to the right the concentration-response curve of oxymetazoline for the inhibition of [3H]-noradrenaline overflow in response to nerve stimulation without depressing the maxima. The pA2 values were 7.82 and 7.52, respectively. 5 Yohimbine (0.1 microM) also antagonized the decrease induced by oxymetazoline in the postsynaptic responses to nerve stimulation. 6 The results confirm the existence of presynaptic inhibitory alpha 2-adrenoceptors at the adrenergic nerve fibres of the rat heart in vitro. Under the stimulation and perfusion conditions selected, the released endogenous transmitter apparently does not activate a negative feedback mechanism, thus permitting the determination of pA2 values.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carr S. R., Fozard J. R. Lack of modulation by presynaptic alpha 2-adrenoceptors of adrenergic transmitters release evoked by activation of 5-hydroxytryptamine and nicotine receptors. Eur J Pharmacol. 1981 Jun 10;72(1):27–34. doi: 10.1016/0014-2999(81)90293-4. [DOI] [PubMed] [Google Scholar]
  3. Doxey J. C., Roach A. G. Presynaptic alpha-adrenoreceptors; in vitro methods and preparations utilised in the evaluation of agonists and antagonists. J Auton Pharmacol. 1980 Nov;1(1):73–99. doi: 10.1111/j.1474-8673.1980.tb00444.x. [DOI] [PubMed] [Google Scholar]
  4. Drew G. M. Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J Pharmacol. 1978 Oct;64(2):293–300. doi: 10.1111/j.1476-5381.1978.tb17303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drew G. M. Presynaptic modulation of heart rate responses to cardiac nerve stimulation in pithed rats. J Cardiovasc Pharmacol. 1980 Nov-Dec;2(6):843–856. doi: 10.1097/00005344-198011000-00013. [DOI] [PubMed] [Google Scholar]
  6. FURCHGOTT R. F. The pharmacology of vascular smooth muscle. Pharmacol Rev. 1955 Jun;7(2):183–265. [PubMed] [Google Scholar]
  7. Fuder H., Rink D., Muscholl E. Sympathetic Nerve Stimulation on the perfused rat heart. Affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):210–219. doi: 10.1007/BF00500482. [DOI] [PubMed] [Google Scholar]
  8. Fuder H., Siebenborn R., Muscholl E. Nicotine receptors do not modulate the 3H-noradrenaline release from the isolated rat heart evoked by sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):301–307. doi: 10.1007/BF00501169. [DOI] [PubMed] [Google Scholar]
  9. Graffe K. H., Stefano F. J., Langer S. Z. Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol. 1973 May 15;22(10):1147–1160. doi: 10.1016/0006-2952(73)90231-1. [DOI] [PubMed] [Google Scholar]
  10. Grundström N., Andersson R. G., Wikberg J. E. Prejunctional alpha 2 adrenoceptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic neurotransmission. Life Sci. 1981 Jun 29;28(26):2981–2986. doi: 10.1016/0024-3205(81)90275-7. [DOI] [PubMed] [Google Scholar]
  11. Kalsner S. Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens. J Pharmacol Exp Ther. 1980 Feb;212(2):232–239. [PubMed] [Google Scholar]
  12. Langer S. Z., Adler-Graschinsky E., Giorgi O. Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation. Nature. 1977 Feb 17;265(5595):648–650. doi: 10.1038/265648a0. [DOI] [PubMed] [Google Scholar]
  13. Langer S. Z., Dubocovich M. L. Cocaine and amphetamine antagonize the decrease of noradrenergic neurotransmission elicited by oxymetazoline but potentiate the inhibition by alpha-methylnorepinephrine in the perfused cat spleen. J Pharmacol Exp Ther. 1981 Jan;216(1):162–171. [PubMed] [Google Scholar]
  14. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Majewski H., Hedler L., Steppeler A., Starke K. Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart. Naunyn Schmiedebergs Arch Pharmacol. 1982 May;319(2):125–129. doi: 10.1007/BF00503924. [DOI] [PubMed] [Google Scholar]
  16. Pelayo F., Dubocovich M. L., Langer S. Z. Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices. Eur J Pharmacol. 1980 Jun 13;64(2-3):143–155. doi: 10.1016/0014-2999(80)90037-0. [DOI] [PubMed] [Google Scholar]
  17. Reichenbacher D., Reimann W., Starke K. alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1982 Apr;319(1):71–77. doi: 10.1007/BF00491481. [DOI] [PubMed] [Google Scholar]
  18. Ruffolo R. R., Jr, Waddell J. E., Yaden E. L. Heterogeneity of postsynaptic Alpha adrenergic receptors in mammalian aortas. J Pharmacol Exp Ther. 1982 May;221(2):309–314. [PubMed] [Google Scholar]
  19. Starke K. Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):18–45. doi: 10.1007/BF00501004. [DOI] [PubMed] [Google Scholar]
  20. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol. 1981;88:199–236. [PubMed] [Google Scholar]
  21. Starke K., Montel H., Gayk W., Merker R. Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction. Naunyn Schmiedebergs Arch Pharmacol. 1974;285(2):133–150. doi: 10.1007/BF00501149. [DOI] [PubMed] [Google Scholar]
  22. Starke K., Montel H., Wagner J. Effect of phentolamine on noradrenaline uptake and release. Naunyn Schmiedebergs Arch Pharmakol. 1971;271(2):181–192. doi: 10.1007/BF00998579. [DOI] [PubMed] [Google Scholar]
  23. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  24. Story D. F., McCulloch M. W., Rand M. J., Standford-Starr C. A. Conditions required for the inhibitory feedback loop in noradrenergic transmission. Nature. 1981 Sep 3;293(5827):62–65. doi: 10.1038/293062a0. [DOI] [PubMed] [Google Scholar]
  25. Wakade A. R., Wakade T. D. Does presynaptic regulation of sympathetic transmission occur within a limited range of neuronal activity? Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):77–79. doi: 10.1007/BF00586354. [DOI] [PubMed] [Google Scholar]
  26. Wakade A. R., Wakade T. D. Release of noradrenaline by one pulse: modulation of such release by alpha-adrenoceptor antagonists and uptake blockers. Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):302–309. doi: 10.1007/BF00501310. [DOI] [PubMed] [Google Scholar]
  27. Wemer J., van der Lugt J. C., de Langen C. D., Mulder A. H. On the capacity of presynaptic alpha receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors. J Pharmacol Exp Ther. 1979 Dec;211(3):445–451. [PubMed] [Google Scholar]
  28. Wikberg J. E. The pharmacological classification of adrenergic alpha 1 and alpha 2 receptors and their mechanisms of action. Acta Physiol Scand Suppl. 1979;468:1–99. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES